BioMarin Reports Second Quarter 2026 Financial and Operating Results
Go back to BioMarin Reports Second Quarter 2026 Financial and Operating Results| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 62.24 -1.13 (1.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.37 | 52 Week High | $108.96 | |||
| Open | $63.68 | 52 Week Low | $62.12 | |||
| Day High | $64.00 | P/E | N/A | |||
| Day Low | $61.94 | EPS | $-1.27 | |||
| Volume | 503,088 | |||||
